Villegas Bruguera Eulalia B, Mata Kevin Molina, de Mandojana Magdalena Fernandez Martinez, Blanco Iosune Guillén, Cánovas Manuel Sánchez
Hospital at Home Service of Consorci Sanitari Integral (CSI), Barcelona, Spain.
Medical Oncology Service, Institut Català d'Oncología (ICO) Hospital Duran i Reynals, Hospital de Bellvitge, L'Hospitalet del Llobregat, L'Hospitalet del Llobregat, Spain.
Clin Transl Oncol. 2025 Apr 23. doi: 10.1007/s12094-025-03875-4.
The number of oncologic patients and survival rates are increasing worldwide. This fact implies greater comorbidity and complications associated with cancer and oncologic therapies. Many of these complications require hospitalization which constitutes an additional risk factor for the patient, due to the nosocomial burden such as infections, severe functional deficits or depression. Moreover, the increasing number of hospitalizations implies a significant increase in global sanitary costs. Hospital at Home (HaH) is a resource that allows decompensated patient to remain in home, attended and treated by a hospital multidisciplinary team. Furthermore, HaH has been shown to be clearly cost-effective in multiple pathologies compared to conventional hospitalization. A group of experts from the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Hospital at Home (SEHAD) met to discuss a brief update on home complex attention of oncologic patients and agree on aspects relating to the clinical diagnosis, admission criteria and management of different profiles.
全球范围内肿瘤患者数量和生存率都在上升。这一事实意味着与癌症及肿瘤治疗相关的合并症和并发症增多。其中许多并发症需要住院治疗，而这又会给患者带来额外风险因素，因为存在诸如感染、严重功能缺陷或抑郁等医院负担。此外，住院次数的增加意味着全球卫生费用大幅上涨。居家医院（HaH）是一种资源，它能让失代偿患者留在家里，由医院多学科团队进行照料和治疗。此外，与传统住院治疗相比，居家医院在多种病症中已被证明具有明显的成本效益。西班牙医学肿瘤学会（SEOM）和西班牙居家医院学会（SEHAD）的一组专家会面，讨论了肿瘤患者居家综合护理的简要最新情况，并就不同病例的临床诊断、入院标准和管理等方面达成了共识。
